HAIKOU CITY, China, March 21, 2014 /PRNewswire/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE MKT: CPHI), an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China, announced today updated dial-in information for its fiscal year 2013 earnings conference call. Below is the updated information.
Fiscal Year Conference Call | |||
Date: | Friday, March 21, 2014 | ||
Time: | 8:30 a.m. ET | ||
Dial#: | US Toll Free: 1 800 742 9301 | ||
Webcast: | |||
Replay
Dial#: | US Toll Free: 1 855 452 5696 Conference ID 8557805 |
A replay of the call will be accessible through March 28, 2014.
About China Pharma Holdings, Inc.
China Pharma Holdings, Inc. is a specialty pharmaceutical company that develops, manufactures and markets a diversified portfolio of products focused on conditions with a high incidence and high mortality rates in China, including cardiovascular, CNS, infectious, and digestive diseases. The Company's cost-effective, high-margin business model is driven by market demand and supported by eight scalable GMP-certified product lines covering the major dosage forms. In addition, the Company has a broad and expanding nationwide distribution network across all major cities and provinces in China. The Company's wholly-owned subsidiary, Hainan Helpson Medical & Biotechnology Co., Ltd., is located in Haikou City, Hainan Province. For more information about China Pharma Holdings, Inc., please visit http://www.chinapharmaholdings.com. The Company routinely posts important information on its website.
China Pharma Holdings, Inc.
86-898-66811730
hps@chinapharmaholdings.com
